Status:
COMPLETED
Group B Streptococcus Response After Probiotic Exposure
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
Marquette University
Conditions:
Group B Strep Infection
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine prenatal probiotic use in Group B Strep (GB...
Detailed Description
This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine prenatal probiotic use in Group B Strep (GB...
Eligibility Criteria
Inclusion
- • Healthy adult (≥ 18 years of age) pregnant women who are 36 - 37 6/7 weeks gestation at enrollment \[calculated from the first day of Last Normal Menstrual Period (LNMP) and/or ultrasound (US)\]
- Group B Streptococcus Positive at 36 weeks gestation with:
- No obstetric complication requiring delivery prior to 39 weeks (hypertensive disorder diagnosed prior to enrollment, gestational diabetes, multiple gestation)
- No fetal complication (e.g., birth defect, intrauterine growth restriction)
- No medical complication (e.g., chronic hypertension, preexisting diabetes mellitus)
- Who do not currently ingest an over the counter probiotic supplement (not including yogurt)
- Who can both speak and read English or Spanish
- Pregnant women who regularly attend UNM prenatal clinics for their prenatal care ("regularly attend" will be defined as starting prenatal care prior to 20 weeks gestation and missing no more than one prenatal appointment during this pregnancy)
- No hypersensitivity reaction to β-lactam antibiotics
Exclusion
- Those less than 18 years of age
- Non-pregnant women
- Later in pregnancy than 38 weeks gestation at enrollment \[per LNMP and/or US\]
- Those with an obstetric, fetal or medical complication of pregnancy
- Group B Streptococcus negative at 36 weeks gestation. Those ineligible for testing at 36 weeks gestation (history of GBS bacteriuria during the current pregnancy or have previously given birth to a GBS affected child.) We will not exclude those with bacteriuria other than GBS, and we will not exclude women who have taken an antibiotic during pregnancy, but we will track this as it is addressed in the Questionnaire for Women.
- Women who are currently ingesting an over the counter probiotic supplement (except for yogurt)
- Women who do not have electricity in the home.
- Women who are planning an elective repeat cesarean birth
- Women who do not speak and read English or Spanish
- Women with a history of missing one or more scheduled prenatal visit during this pregnancy
- Hypersensitivity reaction to β-lactam antibiotics
Key Trial Info
Start Date :
December 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04721912
Start Date
December 24 2020
End Date
August 31 2023
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico Hospital
Albuquerque, New Mexico, United States, 87112